PDCD1 and neoplasm: Notably, the combination of D-mannose with the anti-PD-1/PD-L1 blockade exhibits a pronounced inhibitory effect on the growth of triple-negative breast cancer (TNBC) and extends the lifespan of tumor-bearing mice [67].